IMEL BIOTHERAPEUTICS
Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders. It uses a proprietary mitochondrial replaced cells technology, helping physicians to treat multiple patients with mitochondrial genetic or age-related disorders. The company was founded in 2019 and is based in Waltham, Massachusetts.
IMEL BIOTHERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.imelbiotx.com
Status:
Active
Total Funding:
15.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud OpenResty Google Adsense
Similar Organizations
Athos Therapeutics
Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.imelbiotx.com
- Host name: 80.178.112.44.adsl.012.net.il
- IP address: 80.178.112.44
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
